Completed APOLLO: The Study of an Investigational Drug, Patisiran (ALN-TTR02), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis NCT01960348 Conditions Amyloid Neuropathies, Amyloid Neuropathies, Familial, Amyloidosis, +16 more Locations Clinical Trial Site — La Mesa, California, United States Clinical Trial Site — Orange, California, United States Clinical Trial Site — Denver, Colorado, United States Clinical Trial Site — Chicago, Illinois, United States View all 52 locations View more locations Show fewer locations Loading locations... View Trial Details